Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease

Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease

AbstractObjective Proton pump inhibitor (PPI) use has been associated with reduced diversity of the gut microbiome and may lead to worse clinical outcomes in inflammatory bowel disease (IBD). We aimed to evaluate whether PPI use affects clinical outcomes in a real-world setting.Design Healthcare cla...

Full description

Bibliographic Details
Main Authors: Tenzin Choden, Hui Zhang, Atsushi Sakuraba
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Annals of Medicine
Subjects:
Proton pump inhibitor (PPI)
inflammatory bowel disease (IBD)
Marketscan
biologic use
admission
surgery
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2023.2198775

Internet

https://www.tandfonline.com/doi/10.1080/07853890.2023.2198775

Similar Items